NCT04254601 (LLLT-NBUB) is a NA clinical trial of Narrow band ultraviolet B. in Skin Diseases, sponsored by Cairo University.

Who is sponsoring NCT04254601?

NCT04254601 is sponsored by Cairo University.

What drugs are being tested in NCT04254601?

Interventions in NCT04254601: Narrow band ultraviolet B., topical erythromycin cream 2% (Akne-Mycin- Egypt).

What condition does NCT04254601 study?

NCT04254601 studies Skin Diseases.

Is NCT04254601 still recruiting?

NCT04254601 is currently completed. Last updated 5 February 2020.

Last reviewed 2020-02-05 · How we verify

NCT04254601: LLLT-NBUB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laser Therapy Versus Narrow Band Ultraviolet B for the Treatment of Acne Vulgaris

Completed NA Last updated 5 February 2020

What this trial tests

NA trial testing Narrow band ultraviolet B. in Skin Diseases in 45 participants. Completed in 30 June 2019.

Timeline

1 April 2018

Primary endpoint
30 June 2019

30 June 2019

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	45
Start date	1 April 2018
Primary completion	30 June 2019
Estimated completion	30 June 2019
Sites	1 location across Egypt

Drugs / interventions tested

Narrow band ultraviolet B.
topical erythromycin cream 2% (Akne-Mycin- Egypt) — full drug profile →

Conditions studied

Skin Diseases — all drugs for Skin Diseases →

Sponsor

Cairo University

Who can join

Adults 18 to 35, any sex, with Skin Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Forty-five participants with facial AV were assigned randomly to three groups of fifteen subjects each. Each group received various therapies. Group A (Study group A) had received both NBUB and akne-Mycin; Group B( study group B) had received Red LLLT and akne-Mycin and group C (Control group) received only akne-Mycin cream. All 45 participants are tested at the initial treatments, after 4 weeks and after 8 weeks by the acne count, the intensity scale and the photographic test.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Narrow Band Ultraviolet B Versus Red Light-Emitting Diodes in the Treatment of Facial Acne Vulgaris: A Randomized Controlled Trial.
Eid MM, Saleh MS, Allam NM, Elsherbini DM, et al · · 2021 · cited 3× · PMID 34015228 · DOI 10.1089/photob.2020.4988

Verify or expand the search:

Other recruiting trials for Skin Diseases

Currently open trials in the same condition.

NCT07412691 — A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With Immune-Mediated Skin Diseases · Phase 1 · recruiting
NCT07091604 — An Observational Study to Assess Objective Skin Pigmentation Variation. · recruiting
NCT07158879 — Skin Reactions Related to Thoracic Implantable Chamber Dressings · recruiting
NCT06850311 — Herbal Ointment in Treating Atopic Dermatitis Topically · Phase 2, PHASE3 · recruiting
NCT06563323 — Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Phase 2 · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04254601 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 5 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04254601.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing